Capital Advantage, Inc.

Position in JNJ — Johnson & Johnson

CIK 1628896 Walnut Creek, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$1,317,596

+$12,531 QoQ

Shares Held

5,188

-2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.43%

of 13F equity value

Holder Rank

#2,720

of 4,664 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Advantage, Inc. holds $3,879,621 across 4 Drug Manufacturers - General names. JNJ ranks #1 (34.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	5,188	$1,317,596
2	MRK	Merck & Co., Inc.	7,767	$998,059
3	AMGN	Amgen Inc	2,474	$895,884
4	LLY	ELI LILLY & Co	557	$668,082

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,317,596	5,188	-2.8%	Shares	Sole	2026-07-13
2026-03-31	$1,305,065	5,339	-0.4%	Shares	Sole	2026-04-13
2025-12-31	$1,109,045	5,359	+12.4%	Shares	Sole	2026-01-07
2025-09-30	$884,267	4,769	+0.1%	Shares	Sole	2025-10-22
2025-06-30	$727,395	4,762	-3.0%	Shares	Sole	2025-07-11
2025-03-31	$814,274	4,910	0.0%	Shares	Sole	2025-04-10
2024-12-31	$710,084	4,910	-21.2%	Shares	Sole	2025-02-14
2021-03-31	$1,023,571	6,228	+4.1%	Shares	Sole	2021-04-26
2020-12-31	$941,761	5,984	+1.7%	Shares	Sole	2021-02-17
2020-09-30	$875,861	5,883	-2.0%	Shares	Sole	2020-11-12
2020-06-30	$844,061	6,002	-4.8%	Shares	Sole	2020-08-13
2020-03-31	$826,774	6,305	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.